PharVision Advisers’s VNET Group VNET Stock Holding History

PharVision Advisers’s Portfolio VNET Stock Details VNET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-23,257	Closed	-$197K	–	638
2025 Q4	$197K	Buy	+23,257	New	+$216K	0.1%	565

Other funds holding VNET

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Triata Capital Hong Kong $588M AUM 8.92% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $2.41B AUM 286.33% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

PharVision Advisers's VNET Position: Q1 2026 in Review

PharVision Advisers sold out of VNET Group (VNET) in Q1 2026, closing a stake of 23,257 shares — an estimated $197K sold.

PharVision Advisers first reported a position in VNET in Q4 2025 and held it in 1 quarter. The position peaked at $197K in Q4 2025. 192 funds tracked by Wall St. Rank hold VNET as of Q1 2026.

PharVision Advisers reported no remaining VNET Group position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 23,257 VNET Group shares in Q1 2026, an estimated $197K.
PharVision Advisers first reported a position in VNET Group in Q4 2025 and held it in 1 quarter.
PharVision Advisers's VNET Group position peaked at $197K in Q4 2025.
192 funds tracked by Wall St. Rank held VNET Group as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.